About Ablative Solutions
Ablative Solutions is a company based in Kalamazoo (United States) founded in 2011.. Ablative Solutions has raised $303.65 million across 13 funding rounds from investors including Novus Life Sciences, Gilde Healthcare and Invus. The company has 24 employees as of December 31, 2022. Ablative Solutions offers products and services including Peregrine System. Ablative Solutions operates in a competitive market with competitors including ReCor Medical, Brattea, Autonomix, Kalos Medical and Maya Medical, among others.
- Headquarter Kalamazoo, United States
- Employees 24 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ablative Solutions Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$303.65 M (USD)
in 13 rounds
-
Latest Funding Round
$10.41 M (USD), Series D
Nov 14, 2025
-
Investors
Novus Life Sciences
& 5 more
-
Employee Count
24
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ablative Solutions
Ablative Solutions offers a comprehensive portfolio of products and services, including Peregrine System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Investigational kit for renal denervation to treat hypertension in clinical trials
Unlock access to complete
Unlock access to complete
Funding Insights of Ablative Solutions
Ablative Solutions has successfully raised a total of $303.65M across 13 strategic funding rounds. The most recent funding activity was a Series D round of $10.41 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 13
- Last Round Series D — $10.4M
-
First Round
First Round
(29 Mar 2012)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2025 | Amount | Series D - Ablative Solutions | Valuation |
investors |
|
| Dec, 2024 | Amount | Series D - Ablative Solutions | Valuation |
investors |
|
| Mar, 2023 | Amount | Series D - Ablative Solutions | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ablative Solutions
Ablative Solutions has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Novus Life Sciences, Gilde Healthcare and Invus. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture captial firm focused on healthcare sectors
|
Founded Year | Domain | Location | |
|
Long-term private equity investments in transformational opportunities are pursued.
|
Founded Year | Domain | Location | |
|
Healthtech startups are funded by BioStar Capital's venture capital efforts.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ablative Solutions
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ablative Solutions
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ablative Solutions Comparisons
Competitors of Ablative Solutions
Ablative Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ReCor Medical, Brattea, Autonomix, Kalos Medical and Maya Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Ultrasound-based renal denervation is applied for hypertension treatment.
|
|
| domain | founded_year | HQ Location |
Developer of a medical device for the treatment of hypertension
|
|
| domain | founded_year | HQ Location |
Minimally invasive neural monitoring and treatment devices are developed.
|
|
| domain | founded_year | HQ Location |
Developer of medical devices for the treatment of hypertension & other chronic diseases
|
|
| domain | founded_year | HQ Location |
Catheter based ablative technology for renal denervation to treat hypertension
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ablative Solutions
Frequently Asked Questions about Ablative Solutions
When was Ablative Solutions founded?
Ablative Solutions was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Where is Ablative Solutions located?
Ablative Solutions is headquartered in Kalamazoo, United States. It is registered at Kalamazoo, Michigan, United States.
Is Ablative Solutions a funded company?
Ablative Solutions is a funded company, having raised a total of $303.65M across 13 funding rounds to date. The company's 1st funding round was a Series D of $29.33M, raised on Mar 29, 2012.
How many employees does Ablative Solutions have?
As of Dec 31, 2022, the latest employee count at Ablative Solutions is 24.
What does Ablative Solutions do?
Ablative Solutions was founded in 2011 and is located in Kalamazoo, United States. Renal denervation technologies are developed by the company within the medical device sector to address hypertension. A catheter-based method is used to deliver diagnostic and therapeutic agents to the perivascular space around peripheral blood vessels. The Peregrine system is being evaluated clinically for hypertension management. Operations focus on interventional cardiology solutions.
Who are the top competitors of Ablative Solutions?
Ablative Solutions's top competitors include ReCor Medical, Autonomix and Maya Medical.
What products or services does Ablative Solutions offer?
Ablative Solutions offers Peregrine System.
Who are Ablative Solutions's investors?
Ablative Solutions has 6 investors. Key investors include Novus Life Sciences, Gilde Healthcare, Invus, BioStar Capital, and Charter Capital Partners.